Shielding cancer fighters: can a simple vaccine timing trick prevent deadly infections?
NCT ID NCT04745559
Summary
This study is testing whether giving a pneumonia vaccine before and after a powerful cancer treatment called CAR T cell therapy can better protect patients from serious infections. It involves 26 adults with certain types of B-cell lymphoma who are scheduled for CAR T therapy. The goal is to see if this specific timing helps the body build stronger, longer-lasting defenses against pneumonia.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FOLLICULAR LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Moffitt Cancer Center
Tampa, Florida, 33612, United States
Conditions
Explore the condition pages connected to this study.